Fenway Health will be shutting down at 5 PM on December 24 and December 31 and will be closed on December 25 and January 1 for Christmas and New Year’s.

HPTN 102/Purpose 3 Study: Injectable PrEP for Cisgender Women

Flyer for study - text repeated on page.

Join the HPTN 102/Purpose 3 Study: Injectable PrEP for Cisgender Women

The HPTN 102/Purpose 3 study is exploring the safety and acceptability of an investigational twice-yearly injectable form of PrEP (Pre-Exposure Prophylaxis) for cisgender women.

You may be eligible to participate if:

  • You are a cisgender woman
  • You are 18 years old or older
  • You have had condomless sex with a cisgender man in the last 12 months

 

Qualifying participants may receive up to $700 for study-related time and travel. Complete the pre-screener via the link below and a study team member will contact you if you may be eligible.

redcap.link/P3

For more information and to see if you may be eligible, please call or text 617.927.6450 or email [email protected]

Translate »